These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 33593693)

  • 1. Diversity and Function of Glial Cell Types in Multiple Sclerosis.
    Schirmer L; Schafer DP; Bartels T; Rowitch DH; Calabresi PA
    Trends Immunol; 2021 Mar; 42(3):228-247. PubMed ID: 33593693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-regional homeostatic and reactive glial signatures in multiple sclerosis.
    Trobisch T; Zulji A; Stevens NA; Schwarz S; Wischnewski S; Öztürk M; Perales-Patón J; Haeussler M; Saez-Rodriguez J; Velmeshev D; Schirmer L
    Acta Neuropathol; 2022 Nov; 144(5):987-1003. PubMed ID: 36112223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing RNA-sequencing datasets from astrocytes, oligodendrocytes, and microglia in multiple sclerosis identifies novel dysregulated genes relevant to inflammation and myelination.
    Drake SS; Zaman A; Simas T; Fournier AE
    WIREs Mech Dis; 2023 Mar; 15(2):e1594. PubMed ID: 36600404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of glial cells in multiple sclerosis disease progression.
    Healy LM; Stratton JA; Kuhlmann T; Antel J
    Nat Rev Neurol; 2022 Apr; 18(4):237-248. PubMed ID: 35190704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial Cells as Key Regulators in Neuroinflammatory Mechanisms Associated with Multiple Sclerosis.
    Theophanous S; Sargiannidou I; Kleopa KA
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegeneration and demyelination in multiple sclerosis.
    Garton T; Gadani SP; Gill AJ; Calabresi PA
    Neuron; 2024 Oct; 112(19):3231-3251. PubMed ID: 38889714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connexins in oligodendrocytes and astrocytes: Possible factors for demyelination in multiple sclerosis.
    Xia CY; Xu JK; Pan CH; Lian WW; Yan Y; Ma BZ; He J; Zhang WK
    Neurochem Int; 2020 Jun; 136():104731. PubMed ID: 32201280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of glial cell proliferation in early multiple sclerosis lesions.
    Schönrock LM; Kuhlmann T; Adler S; Bitsch A; Brück W
    Neuropathol Appl Neurobiol; 1998 Aug; 24(4):320-30. PubMed ID: 9775398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering the Enigma of Neuron-Glial Interactions in Neurological Disorders.
    Ahmad SR; Zeyaullah M; AlShahrani AM; Dawria A; Ali H; Mohieldin A; Altijani AA; Razi U; Mehdi M; Akram S; Hussain ER
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):142. PubMed ID: 38682185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro.
    Mitrovic B; Ignarro LJ; Montestruque S; Smoll A; Merrill JE
    Neuroscience; 1994 Aug; 61(3):575-85. PubMed ID: 7969931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial transcriptomics combined with single-nucleus RNA sequencing reveals glial cell heterogeneity in the human spinal cord.
    Chen Y; Wei Y; Liu J; Zhu T; Zhou C; Zhang D
    Neural Regen Res; 2025 Nov; 20(11):3302-3316. PubMed ID: 38934400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glia Connect Inflammation and Neurodegeneration in Multiple Sclerosis.
    Sun Y; Yu H; Guan Y
    Neurosci Bull; 2023 Mar; 39(3):466-478. PubMed ID: 36853544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroglia in Psychiatric Disorders.
    Scuderi C; Verkhratsky A; Parpura V; Li B
    Adv Neurobiol; 2021; 26():3-19. PubMed ID: 34888828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of cytolysin mRNA in glial cells by IFN-gamma: a possible cytotoxic pathway in the CNS.
    Xiao BG; Bao WJ; Bai XF; Link H
    Neuroreport; 1996 Dec; 8(1):329-33. PubMed ID: 9051805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging technologies to study glial cells.
    Hirbec H; Déglon N; Foo LC; Goshen I; Grutzendler J; Hangen E; Kreisel T; Linck N; Muffat J; Regio S; Rion S; Escartin C
    Glia; 2020 Sep; 68(9):1692-1728. PubMed ID: 31958188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity and Molecular Markers for CNS Glial Cells Revealed by Single-Cell Transcriptomics.
    Sun J; Song Y; Chen Z; Qiu J; Zhu S; Wu L; Xing L
    Cell Mol Neurobiol; 2022 Nov; 42(8):2629-2642. PubMed ID: 34704168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis. Interactions between oligodendrocytes and hypertrophic astrocytes and their occurrence in other, nondemyelinating conditions.
    Wu E; Raine CS
    Lab Invest; 1992 Jul; 67(1):88-99. PubMed ID: 1625450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system demyelinating diseases: glial cells at the hub of pathology.
    Coutinho Costa VG; Araújo SE; Alves-Leon SV; Gomes FCA
    Front Immunol; 2023; 14():1135540. PubMed ID: 37261349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial Cells: Role of the Immune Response in Ischemic Stroke.
    Xu S; Lu J; Shao A; Zhang JH; Zhang J
    Front Immunol; 2020; 11():294. PubMed ID: 32174916
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.